Copyright Reports & Markets. All rights reserved.

Global CMO/CDMO Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Request for Sample of this report
Buy now

Table of Contents

    1 CMO/CDMO Market Overview

    • 1.1 Product Overview and Scope of CMO/CDMO
    • 1.2 Classification of CMO/CDMO by Types
      • 1.2.1 Global CMO/CDMO Revenue Comparison by Types (2019-2024)
      • 1.2.2 Global CMO/CDMO Revenue Market Share by Types in 2018
      • 1.2.3 Development
      • 1.2.4 API production
      • 1.2.5 Formulation
    • 1.3 Global CMO/CDMO Market by Application
      • 1.3.1 Global CMO/CDMO Market Size and Market Share Comparison by Applications (2014-2024)
      • 1.3.2 Pharmaceutical Industry
      • 1.3.3 Biotechnology
      • 1.3.4 Other
    • 1.4 Global CMO/CDMO Market by Regions
      • 1.4.1 Global CMO/CDMO Market Size (Million USD) Comparison by Regions (2014-2024)
      • 1.4.1 North America (USA, Canada and Mexico) CMO/CDMO Status and Prospect (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy) CMO/CDMO Status and Prospect (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) CMO/CDMO Status and Prospect (2014-2024)
      • 1.4.4 South America (Brazil, Argentina, Colombia) CMO/CDMO Status and Prospect (2014-2024)
      • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) CMO/CDMO Status and Prospect (2014-2024)
    • 1.5 Global Market Size of CMO/CDMO (2014-2024)

    2 Manufacturers Profiles

    • 2.1 Recipharm
      • 2.1.1 Business Overview
      • 2.1.2 CMO/CDMO Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Recipharm CMO/CDMO Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 AMRI3
      • 2.2.1 Business Overview
      • 2.2.2 CMO/CDMO Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 AMRI3 CMO/CDMO Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Patheon
      • 2.3.1 Business Overview
      • 2.3.2 CMO/CDMO Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Patheon CMO/CDMO Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Aenova
      • 2.4.1 Business Overview
      • 2.4.2 CMO/CDMO Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Aenova CMO/CDMO Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Catalent
      • 2.5.1 Business Overview
      • 2.5.2 CMO/CDMO Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Catalent CMO/CDMO Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Amatsigroup
      • 2.6.1 Business Overview
      • 2.6.2 CMO/CDMO Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Amatsigroup CMO/CDMO Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 WuXi PharmaTech
      • 2.7.1 Business Overview
      • 2.7.2 CMO/CDMO Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 WuXi PharmaTech CMO/CDMO Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 Strides Shasun
      • 2.8.1 Business Overview
      • 2.8.2 CMO/CDMO Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Strides Shasun CMO/CDMO Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 Piramal
      • 2.9.1 Business Overview
      • 2.9.2 CMO/CDMO Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 Piramal CMO/CDMO Revenue, Gross Margin and Market Share (2017-2018)
    • 2.10 Siegfried
      • 2.10.1 Business Overview
      • 2.10.2 CMO/CDMO Type and Applications
        • 2.10.2.1 Product A
        • 2.10.2.2 Product B
      • 2.10.3 Siegfried CMO/CDMO Revenue, Gross Margin and Market Share (2017-2018)

    3 Global CMO/CDMO Market Competition, by Players

    • 3.1 Global CMO/CDMO Revenue and Share by Players (2014-2019)
    • 3.2 Market Concentration Rate
      • 3.2.1 Top 5 CMO/CDMO Players Market Share
      • 3.2.2 Top 10 CMO/CDMO Players Market Share
    • 3.3 Market Competition Trend

    4 Global CMO/CDMO Market Size by Regions

    • 4.1 Global CMO/CDMO Revenue and Market Share by Regions
    • 4.2 North America CMO/CDMO Revenue and Growth Rate (2014-2019)
    • 4.3 Europe CMO/CDMO Revenue and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific CMO/CDMO Revenue and Growth Rate (2014-2019)
    • 4.5 South America CMO/CDMO Revenue and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa CMO/CDMO Revenue and Growth Rate (2014-2019)

    5 North America CMO/CDMO Revenue by Countries

    • 5.1 North America CMO/CDMO Revenue by Countries (2014-2019)
    • 5.2 USA CMO/CDMO Revenue and Growth Rate (2014-2019)
    • 5.3 Canada CMO/CDMO Revenue and Growth Rate (2014-2019)
    • 5.4 Mexico CMO/CDMO Revenue and Growth Rate (2014-2019)

    6 Europe CMO/CDMO Revenue by Countries

    • 6.1 Europe CMO/CDMO Revenue by Countries (2014-2019)
    • 6.2 Germany CMO/CDMO Revenue and Growth Rate (2014-2019)
    • 6.3 UK CMO/CDMO Revenue and Growth Rate (2014-2019)
    • 6.4 France CMO/CDMO Revenue and Growth Rate (2014-2019)
    • 6.5 Russia CMO/CDMO Revenue and Growth Rate (2014-2019)
    • 6.6 Italy CMO/CDMO Revenue and Growth Rate (2014-2019)

    7 Asia-Pacific CMO/CDMO Revenue by Countries

    • 7.1 Asia-Pacific CMO/CDMO Revenue by Countries (2014-2019)
    • 7.2 China CMO/CDMO Revenue and Growth Rate (2014-2019)
    • 7.3 Japan CMO/CDMO Revenue and Growth Rate (2014-2019)
    • 7.4 Korea CMO/CDMO Revenue and Growth Rate (2014-2019)
    • 7.5 India CMO/CDMO Revenue and Growth Rate (2014-2019)
    • 7.6 Southeast Asia CMO/CDMO Revenue and Growth Rate (2014-2019)

    8 South America CMO/CDMO Revenue by Countries

    • 8.1 South America CMO/CDMO Revenue by Countries (2014-2019)
    • 8.2 Brazil CMO/CDMO Revenue and Growth Rate (2014-2019)
    • 8.3 Argentina CMO/CDMO Revenue and Growth Rate (2014-2019)
    • 8.4 Colombia CMO/CDMO Revenue and Growth Rate (2014-2019)

    9 Middle East and Africa Revenue CMO/CDMO by Countries

    • 9.1 Middle East and Africa CMO/CDMO Revenue by Countries (2014-2019)
    • 9.2 Saudi Arabia CMO/CDMO Revenue and Growth Rate (2014-2019)
    • 9.3 UAE CMO/CDMO Revenue and Growth Rate (2014-2019)
    • 9.4 Egypt CMO/CDMO Revenue and Growth Rate (2014-2019)
    • 9.5 Nigeria CMO/CDMO Revenue and Growth Rate (2014-2019)
    • 9.6 South Africa CMO/CDMO Revenue and Growth Rate (2014-2019)

    10 Global CMO/CDMO Market Segment by Type

    • 10.1 Global CMO/CDMO Revenue and Market Share by Type (2014-2019)
    • 10.2 Global CMO/CDMO Market Forecast by Type (2019-2024)
    • 10.3 Development Revenue Growth Rate (2014-2024)
    • 10.4 API production Revenue Growth Rate (2014-2024)
    • 10.5 Formulation Revenue Growth Rate (2014-2024)

    11 Global CMO/CDMO Market Segment by Application

    • 11.1 Global CMO/CDMO Revenue Market Share by Application (2014-2019)
    • 11.2 CMO/CDMO Market Forecast by Application (2019-2024)
    • 11.3 Pharmaceutical Industry Revenue Growth (2014-2019)
    • 11.4 Biotechnology Revenue Growth (2014-2019)
    • 11.5 Other Revenue Growth (2014-2019)

    12 Global CMO/CDMO Market Size Forecast (2019-2024)

    • 12.1 Global CMO/CDMO Market Size Forecast (2019-2024)
    • 12.2 Global CMO/CDMO Market Forecast by Regions (2019-2024)
    • 12.3 North America CMO/CDMO Revenue Market Forecast (2019-2024)
    • 12.4 Europe CMO/CDMO Revenue Market Forecast (2019-2024)
    • 12.5 Asia-Pacific CMO/CDMO Revenue Market Forecast (2019-2024)
    • 12.6 South America CMO/CDMO Revenue Market Forecast (2019-2024)
    • 12.7 Middle East and Africa CMO/CDMO Revenue Market Forecast (2019-2024)

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Methodology

      At a time when pharmaceutical companies face increasing price pressures around the globe from key payers, including public and government insurance systems, reducing operational expenses is a major driver of outsourcing pharmaceutical manufacturing to CDMOs. Also, an increasing number of pharmaceutical companies are refocusing on their core capabilities and strengths, leading to divestments of in-house manufacturing capacities in some areas and to a gro

      Scope of the Report:
      The global CMO/CDMO market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
      The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
      North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of CMO/CDMO.
      Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
      This report studies the CMO/CDMO market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the CMO/CDMO market by product type and applications/end industries.

      Market Segment by Companies, this report covers
      Recipharm
      AMRI3
      Patheon
      Aenova
      Catalent
      Amatsigroup
      WuXi PharmaTech
      Strides Shasun
      Piramal
      Siegfried

      Market Segment by Regions, regional analysis covers
      North America (United States, Canada and Mexico)
      Europe (Germany, France, UK, Russia and Italy)
      Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
      South America (Brazil, Argentina, Colombia)
      Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

      Market Segment by Type, covers
      Development
      API production
      Formulation

      Market Segment by Applications, can be divided into
      Pharmaceutical Industry
      Biotechnology
      Other

      Buy now